PKNOX1 (PBX/knotted 1 homeobox 1) is a member of the three-amino acid loop extension (TALE) homeodomain transcription factor family. It regulates genes involved in embryogenesis, hematopoiesis, and tumorigenesis . Antibodies targeting PKNOX1 enable researchers to investigate its expression, localization, and functional roles in health and disease.
Commercial PKNOX1 antibodies are typically rabbit polyclonal or monoclonal reagents validated for applications such as Western blot (WB), immunohistochemistry (IHC), and immunoprecipitation (IP). Key features include:
Validation: For example, Proteintech’s antibody detects PKNOX1 in SH-SY5Y, COLO 320, and HepG2 cells .
Epitope Specificity: Most antibodies target recombinant PKNOX1 fusion proteins or specific peptide sequences .
Stomach Adenocarcinoma (STAD):
PKNOX1 is overexpressed in STAD tumors and correlates with poor survival . Knockdown via siRNA reduced cell viability, migration, and epithelial-mesenchymal transition (EMT) in vitro .
Mechanistically, PKNOX1 activates the hedgehog pathway by directly binding to the DHH promoter, promoting tumor progression .
Spermatogenesis: PKNOX1 antibodies localized the protein in murine testis, revealing its role in germ cell differentiation .
Embryogenesis: PKNOX1 is indispensable for embryonic development, with knockout models showing lethal phenotypes .
PKNOX1 antibodies have been instrumental in studying: